Literature DB >> 31648706

Evolocumab Treatment of Hypercholesterolemia in OSLER-1: Enduring Efficacy, Tolerability, and Safety Over 5 Years.

M John Chapman1, Henry N Ginsberg2.   

Abstract

Entities:  

Keywords:  LDL-cholesterol; PCSK9; atherosclerotic cardiovascular disease; evolocumab; randomized controlled trial

Mesh：

Substances：

Year:  2019        PMID： 31648706     DOI： 10.1016/j.jacc.2019.07.087

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  1 in total

Review 1.  Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges.

Authors:  Chris Packard; M John Chapman; Mahendra Sibartie; Ulrich Laufs; Luis Masana
Journal:  Heart       Date:  2021-04-01       Impact factor: 5.994
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.